1. Home
  2. NXPLW vs RGLS Comparison

NXPLW vs RGLS Comparison

Compare NXPLW & RGLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXPLW
  • RGLS
  • Stock Information
  • Founded
  • NXPLW N/A
  • RGLS 2007
  • Country
  • NXPLW United States
  • RGLS United States
  • Employees
  • NXPLW 166
  • RGLS N/A
  • Industry
  • NXPLW Telecommunications Equipment
  • RGLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • NXPLW Telecommunications
  • RGLS Health Care
  • Exchange
  • NXPLW Nasdaq
  • RGLS Nasdaq
  • Market Cap
  • NXPLW N/A
  • RGLS N/A
  • IPO Year
  • NXPLW N/A
  • RGLS 2012
  • Fundamental
  • Price
  • NXPLW $0.23
  • RGLS $1.75
  • Analyst Decision
  • NXPLW
  • RGLS Strong Buy
  • Analyst Count
  • NXPLW 0
  • RGLS 5
  • Target Price
  • NXPLW N/A
  • RGLS $11.80
  • AVG Volume (30 Days)
  • NXPLW 6.4K
  • RGLS 2.2M
  • Earning Date
  • NXPLW 03-31-2025
  • RGLS 03-13-2025
  • Dividend Yield
  • NXPLW N/A
  • RGLS N/A
  • EPS Growth
  • NXPLW N/A
  • RGLS N/A
  • EPS
  • NXPLW N/A
  • RGLS N/A
  • Revenue
  • NXPLW $66,482,000.00
  • RGLS N/A
  • Revenue This Year
  • NXPLW N/A
  • RGLS N/A
  • Revenue Next Year
  • NXPLW N/A
  • RGLS N/A
  • P/E Ratio
  • NXPLW N/A
  • RGLS N/A
  • Revenue Growth
  • NXPLW 179.89
  • RGLS N/A
  • 52 Week Low
  • NXPLW $0.25
  • RGLS $0.83
  • 52 Week High
  • NXPLW $0.26
  • RGLS $2.90
  • Technical
  • Relative Strength Index (RSI)
  • NXPLW N/A
  • RGLS 67.53
  • Support Level
  • NXPLW N/A
  • RGLS $1.27
  • Resistance Level
  • NXPLW N/A
  • RGLS $2.05
  • Average True Range (ATR)
  • NXPLW 0.00
  • RGLS 0.19
  • MACD
  • NXPLW 0.00
  • RGLS 0.04
  • Stochastic Oscillator
  • NXPLW 0.00
  • RGLS 61.54

About NXPLW NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

Share on Social Networks: